242 related articles for article (PubMed ID: 18716861)
1. T regulatory cells in autoimmune diabetes: past challenges, future prospects.
Bluestone JA; Tang Q; Sedwick CE
J Clin Immunol; 2008 Nov; 28(6):677-84. PubMed ID: 18716861
[TBL] [Abstract][Full Text] [Related]
2. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.
You S; Leforban B; Garcia C; Bach JF; Bluestone JA; Chatenoud L
Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6335-40. PubMed ID: 17389382
[TBL] [Abstract][Full Text] [Related]
3. Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells.
Bour-Jordan H; Salomon BL; Thompson HL; Szot GL; Bernhard MR; Bluestone JA
J Clin Invest; 2004 Oct; 114(7):979-87. PubMed ID: 15467837
[TBL] [Abstract][Full Text] [Related]
4. Abrogation of ICOS/ICOS ligand costimulation in NOD mice results in autoimmune deviation toward the neuromuscular system.
Prevot N; Briet C; Lassmann H; Tardivel I; Roy E; Morin J; Mak TW; Tafuri A; Boitard C
Eur J Immunol; 2010 Aug; 40(8):2267-76. PubMed ID: 20544729
[TBL] [Abstract][Full Text] [Related]
5. Peripherally induced regulatory T cells contribute to the control of autoimmune diabetes in the NOD mouse model.
Schuster C; Jonas F; Zhao F; Kissler S
Eur J Immunol; 2018 Jul; 48(7):1211-1216. PubMed ID: 29604048
[TBL] [Abstract][Full Text] [Related]
6. Self-Transducible Bimodal PDX1-FOXP3 Protein Lifts Insulin Secretion and Curbs Autoimmunity, Boosting Tregs in Type 1 Diabetic Mice.
Amatya C; Radichev IA; Ellefson J; Williams M; Savinov AY
Mol Ther; 2018 Jan; 26(1):184-198. PubMed ID: 28988715
[TBL] [Abstract][Full Text] [Related]
7. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.
Salomon B; Bluestone JA
Annu Rev Immunol; 2001; 19():225-52. PubMed ID: 11244036
[TBL] [Abstract][Full Text] [Related]
8. Exposure to DDT metabolite p,p'-DDE increases autoimmune type 1 diabetes incidence in NOD mouse model.
Cetkovic-Cvrlje M; Olson M; Schindler B; Gong HK
J Immunotoxicol; 2016; 13(1):108-18. PubMed ID: 25721050
[TBL] [Abstract][Full Text] [Related]
9. TCR gamma delta intraepithelial lymphocytes are required for self-tolerance.
Locke NR; Stankovic S; Funda DP; Harrison LC
J Immunol; 2006 Jun; 176(11):6553-9. PubMed ID: 16709812
[TBL] [Abstract][Full Text] [Related]
10. Role of the B7-CD28/CTLA-4 pathway in autoimmune disease.
Chang TT; Kuchroo VK; Sharpe AH
Curr Dir Autoimmun; 2002; 5():113-30. PubMed ID: 11826754
[No Abstract] [Full Text] [Related]
11. The NOD mouse: a model of immune dysregulation.
Anderson MS; Bluestone JA
Annu Rev Immunol; 2005; 23():447-85. PubMed ID: 15771578
[TBL] [Abstract][Full Text] [Related]
12. Treg vaccination in autoimmune type 1 diabetes.
Serr I; Weigmann B; Franke RK; Daniel C
BioDrugs; 2014 Feb; 28(1):7-16. PubMed ID: 23959795
[TBL] [Abstract][Full Text] [Related]
13. Dynamic changes of the Th17/Tc17 and regulatory T cell populations interfere in the experimental autoimmune diabetes pathogenesis.
Yaochite JN; Caliari-Oliveira C; Davanso MR; Carlos D; Malmegrim KC; Cardoso CR; Ramalho LN; Palma PV; da Silva JS; Cunha FQ; Covas DT; Voltarelli JC
Immunobiology; 2013 Mar; 218(3):338-52. PubMed ID: 22704522
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulation of antigen presenting cells promotes natural regulatory T cells that prevent autoimmune diabetes in NOD mice.
Richer MJ; Lavallée DJ; Shanina I; Horwitz MS
PLoS One; 2012; 7(2):e31153. PubMed ID: 22355341
[TBL] [Abstract][Full Text] [Related]
15. B-Lymphocyte Phenotype Determines T-Lymphocyte Subset Differentiation in Autoimmune Diabetes.
Egia-Mendikute L; Arpa B; Rosell-Mases E; Corral-Pujol M; Carrascal J; Carrillo J; Mora C; Chapman H; Panosa A; Vives-Pi M; Stratmann T; Serreze D; Verdaguer J
Front Immunol; 2019; 10():1732. PubMed ID: 31428087
[TBL] [Abstract][Full Text] [Related]
16. Suppressor T cells--they're back and critical for regulation of autoimmunity!
Chatenoud L; Salomon B; Bluestone JA
Immunol Rev; 2001 Aug; 182():149-63. PubMed ID: 11722631
[TBL] [Abstract][Full Text] [Related]
17. B Cells Drive Autoimmunity in Mice with CD28-Deficient Regulatory T Cells.
Zhang R; Sage PT; Finn K; Huynh A; Blazar BR; Marangoni F; Mempel TR; Sharpe AH; Turka LA
J Immunol; 2017 Dec; 199(12):3972-3980. PubMed ID: 29093061
[TBL] [Abstract][Full Text] [Related]
18. A selective CD28 antagonist and rapamycin synergise to protect against spontaneous autoimmune diabetes in NOD mice.
Besançon A; Goncalves T; Valette F; Mary C; Vanhove B; Chatenoud L; You S
Diabetologia; 2018 Aug; 61(8):1811-1816. PubMed ID: 29845333
[TBL] [Abstract][Full Text] [Related]
19. High self-reactivity drives T-bet and potentiates Treg function in tissue-specific autoimmunity.
Sprouse ML; Scavuzzo MA; Blum S; Shevchenko I; Lee T; Makedonas G; Borowiak M; Bettini ML; Bettini M
JCI Insight; 2018 Jan; 3(2):. PubMed ID: 29367462
[TBL] [Abstract][Full Text] [Related]
20. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes.
Salomon B; Lenschow DJ; Rhee L; Ashourian N; Singh B; Sharpe A; Bluestone JA
Immunity; 2000 Apr; 12(4):431-40. PubMed ID: 10795741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
